IP Library Granted Patent US 9,120,820
Granted Patent B2
US 9,120,820 · App. 13/475,618 · Granted Sep 1, 2015

Fluorescent molecular probes for use in assays that measure test compound competitive binding with SAM-utilizing proteins

Inventors: Stephen Douglas Barrett (Hartland, MI); Daniel Austin Bochar (Ann Arbor, MI); Levi Lynn Blazer (Ann Arbor, MI); Fred Lawrence Ciske (Dexter, MI); Gregory William Endres (Saline, MI); Jeffrey Keith Johnson (Ann Arbor, MI); Gregory Scott Keyes (Dexter, MI); Ranjinder Singh Sidhu (Ann Arbor, MI); Raymond C. Trievel (Ypsilanti, MI); Margaret Lynn Collins (Canton, MI)
Assignees: CAYMAN CHEMICAL COMPANY, INCORPORATED; THE REGENTS OF THE UNIVERSITY OF MICHIGAN
C07D519/00G01N21/6428
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,120,820
App. No.
13/475,618
Granted
Sep 1, 2015
Kind
B2
Abstract

Assay methods may generally comprise forming homogeneous assay mixtures comprising target SAM-utilizing protein, fluorescent detection analyte, and test compound, incubating, and measuring FP or TR-FRET signal emitted in order to determine a measure of test compound-SAM -utilizing protein binding. Assay mixtures comprise a SAM-utilizing protein, and a fluorescent detection analyte that binds with the SAM-utilizing protein in the absence of test compound. Assay mixtures may further comprise a test compound. Assay mixture embodiments may generate FP or TR-FRET signal properties that are a function of the inherent binding interactions of both the test compound and the detection analyte with the SAM-utilizing protein. Fluorescent detection analytes comprise a fluorophore moiety, a covalent linker moiety, and a SAM-utilizing protein ligand moiety and could be utilized in FP or TR-FRET assays to measure test compound binding.

Claims (10)

1. A fluorescent detection analyte having the structure of Formula (II):

wherein any two of R 2 , R 2′ , and R 3′ R 3′ are hydrogen and the third is a linker component having a linker moiety bonded to a fluorophore moiety.

2. A fluorescent detection analyte having the structure of Formula (III):

wherein any two of R 2 , R 2′ , and R 3′ are hydrogen and the third is a linker component having a linker moiety bonded to a fluorophore moiety.

3. A fluorescent detection analyte having the structure of Formula (IV):

wherein any two of R 2 , R 2′ , and R 3′ R 3′ are hydrogen and the third is a linker component-having a linker moiety bonded to a fluorophore moiety and wherein R is hydrogen, C 1-8 alkyl, C 2-6 alkynyl, C 3-6 cycloalkyl, C 6-10 aryl, five-to-ten membered heteosryl, five- to ten-membered heterocycyl, C 1-8 acyl, or [(S)-2-aminobutanoic acid]-4-yl.

4. A fluorescent detection analyte selected from the group consisting of Sinefungin Probe 1A, Sinefungin Probe 1B, Sinefungin Probe 2A, Sinefungin Probe 2B, Sinefungin Probe 3, Sinefungin Probe 4, Sinefungin Probe 5, Sinefungin Probe 6, Sinefungin Probe 7, Sinefungin Probe 8, Sinefungin Probe 9, Sinefungin Probe 10, Sinefungin Probe 11, Sinefungin Probe 12, Sinefungin Probe 13; wherein any A − is PF 6 or trifluoroacetate, or a mixture thereof, each respectively illustrated blow:

5. A fluorescent detection analyte selected from the group consisting of Thioadenosine Probe 1 and Thioadenosine Probe 2 eachrespectively illustrated blow:

6. A fluorescent detection analyte selected from the group consisting of Aza-adenosine Probe 1, Aza-adenosine Probe 3, Aza-adenosine Probe 5, Aza-adenosine Probe 6, Aza-adenosine Probe 7, Aza-adenosine Probe 8, Aza -adenosine 9, Aza-adenosine Probe 10, Aza-adenosine Probe 11, each respectively illustrated below:

7. A fluorescent detection analyte selected from the group consisting of Aza-adenosine Probe 2, Aza-adenosine Probe 4, Aza-adenosine Probe 12, Aza-adenosine Probe 13, Aza-adenosine Probe 14, Aza-adenosine Probe 15, Aza -adenosine Probe 16, Aza-adenosine Probe 17, Aza-adenosine Probe 18, Aza-adenosine Probe 19, Aza -adenosine Probe 20, and Aza-adenosine Probe 21, each respectively illustrated blow:

Assignments (4)
CONFIRMATORY LICENSE Recorded Jul 13, 2012
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028553/0834 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S ADDRESS FROM 503 THOMPSON STREET, ANN ARBOR, MI 48104 TO 1600 HURON PARKWAY, 2ND FLOOR, ANN ARBOR, MI 48109-2590 PREVIOUSLY RECORDED ON REEL 028236 FRAME 0367. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE'S ADDRESS. Recorded May 22, 2012
From: TRIEVEL, RAYMOND C.
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 028252/0523 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2012
From: BARRETT, STEPHEN DOUGLAS; BOCHAR, DANIEL AUSTIN; BLAZER, LEVI LYNN; CISKE, FRED LAWRENCE; ENDRES, GREGORY WILLIAM; JOHNSON, JEFFREY KEITH; KEYES, GREGORY SCOTT; SIDHU, RANJINDER SINGH; COLLINS, MARGARET LYNN
To: CAYMAN CHEMICAL COMPANY, INCORPORATED
Reel/Frame 028236/0327 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2012
From: TRIEVEL, RAYMOND C.
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 028236/0367 →
Continuity (2)
Provisional Application 61487461 · May 18, 2011
Related Publication 20120295283A1 · Nov 22, 2012